|
Volumn 24, Issue 2, 2013, Pages 153-160
|
Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: A prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life
|
Author keywords
Double dose; Histamine H1 antagonist; Quality of life; Skindex 16; Urticaria
|
Indexed keywords
ALELOCK;
CETIRIZINE;
OLOPATADINE;
UNCLASSIFIED DRUG;
ADOLESCENT;
ADULT;
ARTICLE;
CLINICAL ASSESSMENT;
COMPARATIVE STUDY;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PRURITUS;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
URTICARIA;
ADOLESCENT;
ADULT;
ANTI-ALLERGIC AGENTS;
CETIRIZINE;
DIBENZOXEPINS;
DOUBLE-BLIND METHOD;
FEMALE;
HISTAMINE H1 ANTAGONISTS, NON-SEDATING;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
PRURITUS;
QUALITY OF LIFE;
TREATMENT OUTCOME;
URTICARIA;
|
EID: 84875319555
PISSN: 09546634
EISSN: 14711753
Source Type: Journal
DOI: 10.3109/09546634.2011.608783 Document Type: Article |
Times cited : (20)
|
References (9)
|